跳至主要内容
临床试验/NCT07007715
NCT07007715招募中不适用

Optimizing High-flow Nasal Cannula Settings: Comparing Different Flow Approaches and Exploring Physiological Phenotyping With End-expiratory Lung Volume, Peak Tidal Inspiratory Flow and Oxygen Demand

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 480 人开始时间: 2025年6月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
480
试验地点
1
主要终点
A composite outcome of noninvasive ventilation (NIV) use or reintubation within five days after extubation

研究概览

简要总结

The goal of this randomized trial is to compare four different flow-setting approaches for post-extubation use of high-flow nasal cannula (HFNC). Selecting the appropriate flow rate when initiating HFNC oxygen therapy is both crucial and challenging for clinicians, as the physiological benefits of HFNC depend significantly on the flow rate. To date, there are no guidelines or consensus on flow-rate setting and weaning for HFNC oxygen therapy.

The investigators hypothesized that physiological marker-guided flow setting using peak tidal inspiratory flow (PTIF) or PaO₂/FiO₂ ratios lead to better extubation outcomes as compared to empirical flow setting of 40 L/min or 60 L/min.

Participants will be randomly assigned to one of four study groups with different flow setting strategies summarized as follows: (1) Setting flow at 40 L/min, (2) Setting flow at 5 L/min above the peak tidal inspiratory flow, up to a maximum of 60 L/min. (3) Setting flow according to P/F ratio prior to extubation. Flow will be set at 60, 50 40 L/min if P/F ratio <250 mmHg, 250-300 mmHg and >300 mmHg, respectively. (4) Setting flow at 60 L/min.

详细描述

High-flow nasal cannula (HFNC) is a promising intervention for post-extubation oxygen therapy, with the potential to improve oxygenation, increase end-expiratory lung volume (EELV), reduce the work of breathing, and lower the risk of reintubation. Selecting an appropriate flow rate when initiating HFNC therapy is both crucial and challenging for clinicians. Although the physiological benefits of HFNC depend significantly on the flow rate, arbitrarily applying higher flow rates without appropriate patient selection may increase the risk of barotrauma and patient discomfort. Currently, there are no established guidelines or consensus on flow-rate setting for HFNC therapy. Given the growing use of HFNC, determining the optimal flow-setting strategy is urgently needed to ensure both clinical efficacy and cost-effectiveness.

This 4-arm parallel-group randomized trial aims to compare four different flow-setting approaches for post-extubation use of HFNC in extubation outcomes. The individual flow-setting strategy for each study arm is summarized as follows: (1) Setting flow at 40 L/min, (2) Setting flow at 5 L/min above the peak tidal inspiratory flow, up to a maximum of 60 L/min. (3) Setting flow according to P/F ratio prior to extubation. Flow will be set at 60, 50 40 L/min if P/F ratio <250 mmHg, 250-300 mmHg and >300 mmHg, respectively. (4) Setting flow at 60 L/min. In addition, this study will incorporate measurements of peak tidal inspiratory flow and EELV to highlight the physiological characteristics of individual patients. These physiological measures may serve as both explanatory variables and potential predictors of flow responders. By examining the associations among flow responders, peak tidal inspiratory flow, pre-extubation oxygen demand, and changes in EELV, we aim to develop a comprehensive understanding of the mechanisms and key factors influencing flow responsiveness during post-extubation care with HFNC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Intubated and receiving mechanical ventilation for more than 24 hours
  • •Ready for planned extubation after passing a spontaneous breathing trial
  • •PaO2/FiO2 <350 mmHg on the day of extubation

排除标准

  • •Age <18 years
  • •On do-not-reintubate code
  • •Pregnant women
  • •Having tracheostomies
  • •Infeasibility of using HFNC
  • •Planning to use preventive NIV after extubation by the primary care team
  • •Life expectancy less than one month

研究组 & 干预措施

Flow of 60L/min

Experimental

Setting HFNC flow at 60 L/min

干预措施: Flow of 60L/min (Other)

Flow of 40L/min

Active Comparator

Setting HFNC flow at 40 L/min

干预措施: Flow of 40L/min (Other)

Peak tidal inspiratory flow (PTIF) guided

Experimental

Setting HFNC flow at 5 L/min above the peak tidal inspiratory flow (PTIF), up to a maximum of 60 L/min.

干预措施: Peak tidal inspiratory flow (PTIF) guided (Other)

PaO2/FiO2 ratio guided

Experimental

Setting HFNC flow according to P/F ratio prior to extubation. Flow will be set at 60, 50 40 L/min if P/F ratio <250 mmHg, 250-300 mmHg and >300 mmHg, respectively.

干预措施: PaO2/FiO2 ratio guided (Other)

结局指标

主要结局

A composite outcome of noninvasive ventilation (NIV) use or reintubation within five days after extubation

时间窗: 5 days

A single global test of significance to compare between-group difference in the composite outcome

次要结局

  • Proportion of reintubation within five days after extubation(5 days)
  • Proportion of NIV use within five days after extubation(5 days)
  • 28-day mortality(28 days)
  • Change in PaO2/FiO2 ratio between 0 and 24th hour(24 hours)
  • Change in arterial CO2 level (mmHg) between 0 and 24th hour(24 hours)
  • Proportion of ahead-of-schedule change in flow rates in 24 hours(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

National Taiwan University Clinical Trial Center

Sheng-Yuan Ruan, MD

National Taiwan University Hospital

研究点 (1)

Loading locations...

相似试验